Molly Freeman explains why it is necessary for providers to be educated on stereotactic body radiation therapy.
Molly Freeman, CNP, Cleveland Clinic Cancer Center, discusses the importance of providers being familiar with SBRT and what the effects look like.
If a provider is unaware of what the effects of stereotactic body radiation therapy (SBRT) look like on a scan, it can cause alarm. This can sometimes lead to unnecessary biopsy or other treatment. To combat this, Freeman suggests more education for both patients and providers and sending copies of scans to the radiation oncologist for review.
Evolution of Frontline VEGF TKI/Immunotherapy Treatments Propels Field of Renal Cell Carcinoma
August 10th 2022In a presentation at the 6th Annual School of Nursing Oncology™, Laura Wood, RN, MSN, OCN, highlights key nurse takeaways with VEGF TKI/immune checkpoint inhibitor therapy for patients with renal cell carcinoma.
Pollack Discusses Ongoing Research for Patients With Refractory mCRC and Other Hard-to-Treat GI Malignancies
Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium
Nivolumab/Cabozantinib Shows Continued Benefit In Frontline Treatment of RCC
Goodman Highlights Potential Benefit of SBRT in Locally Advanced Pancreatic Cancer
2 Clarke Drive
Cranbury, NJ 08512